Thursday, September 16, 2021

Corrected Link for National Stakeholder Call with the CMS Administrator; Public Listening Opportunities

Centers for Medicare & Medicaid Services
Quality Payment Program

Corrected link for CMS National Stakeholder Call on Friday, September 17 at 12:30

You are invited to join the Administrator of the Centers for Medicare & Medicaid Services' (CMS), Chiquita Brooks-LaSure, and her leadership team, to hear key updates from her first 100 days in office. The Administrator's vision is for CMS to serve the public as a trusted partner and steward, dedicated to advancing health equity, expanding coverage, and improving health outcomes. We invite you to join us for this first national stakeholder call to learn more about how you can partner with us as we implement our vision. 

When: September 17, 2021 from 12:30 PM ET - 1:00 PM ET

Speakers:  

  • CMS Administrator, Chiquita Brooks-LaSure
  • CMS Leadership team

Who should attend: National and local stakeholders and partners

To Join the Call Click Here:

https://cms.zoomgov.com/j/1619106718?pwd=RGdzcmI2TENZMmVLcHU1ZjgwSHhIdz09

Call: 833 568 8864 (Toll Free)

Webinar ID: 161 910 6718

Passcode: 891135

Questions:  We want to hear from you. Questions can be submitted in advance of the webinar by emailing Partnership@cms.hhs.gov.


Public Listening Opportunities: CKD/ESRD and Psychoses/Related Conditions Clinician Expert Workgroup Webinars

CMS has contracted with Acumen, LLC to develop episode-based cost measures for their potential use in the cost performance category of the Merit-based Incentive Payment System (MIPS). As part of measure development, Acumen convenes Clinician Expert Workgroups ("workgroups") to provide input on all components of cost measure specifications.

Acumen is hosting 2 part-day virtual webinars that are open to the public with a listen-only option.  Stakeholders and members of the public are invited to listen in on the considerations that inform cost measure development. Please share this message with anyone you believe may be interested.

The dates and times for the upcoming webinars are listed below. To register, please click on the webinar(s) you're interested in attending:

The CKD/ESRD measures are a re-specification for MIPS of the cost measures that were developed for the Kidney Care First Option of the Kidney Care Choices (KCC) Alternative Payment Model in 2020. More information on the KCC model is available here, and a report summarizing expert input from the Technical Expert Panel that Acumen convened is available here.

The Psychoses/Related Conditions measure was one of 11 episode-based cost measures developed between April and December 2018. During the 2018-2019 pre-rulemaking process, the Measure Applications Partnership (MAP) conditionally supported 10 measures, but re-voted on the Psychoses/Related Conditions measure with 'do not support' for rulemaking. Since then, Acumen has continued to gather feedback about refining the measure through multiple channels.

Information about the measure development process and development activities (including this process summary document) undertaken in previous years is on the MACRA Feedback Page.

If you have any questions about measure development, workgroups, or the workgroup meetings, please contact Acumen at macra-clinical-committee-support@acumenllc.com. If you would like to receive measure development updates, please join our mailing list.

If you have questions about MIPS, the cost performance category, or cost measures currently in use in MIPS, please contact the Quality Payment Program at 1-866-288-8292 or by e-mail at QPP@cms.hhs.gov (Monday-Friday 8 a.m. - 8 p.m. ET). To receive assistance more quickly, please consider calling during non-peak hours—before 10 a.m. and after 2 p.m. ET.

  • Customers who are hearing impaired can dial 711 to be connected to a TRS Communications Assistant.

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud 7500 Security Boulevard · Baltimore MD 21244

No comments:

Post a Comment

Top 4 Under-the-Radar Stocks for 2024

Unsubscribe       Four Undervalued Nasdaq Stocks Poised to Deliver High Ups...